Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension

1Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

A 65-year-old woman with a 35-year history of limited cutaneous systemic scleroderma was admitted to our hospital complaining of a 3-month history of progressive dyspnoea on exertion. High-resolution CT images of the chest revealed diffuse reticular opacities and traction bronchiectasis predominantly in the bilateral lower lobes of the lung. Specimens obtained during video-assisted thoracic surgery were consistent with fibrocellular non-specific interstitial pneumonia and accompanied by accumulation of lymph follicles within areas of fibrosis. Although the patient received combination therapy with prednisolone and intravenous cyclophosphamide at a dosage of 500 mg/m 2 monthly for 5 months, her clinical condition deteriorated gradually. In addition, right heart catheterisation revealed borderline pulmonary arterial hypertension with mean pulmonary artery pressure of 24 mm Hg. Therefore, we initiated a combination therapy of an antifibrotic agent, pirfenidone for 12 months, and the dual endothelin receptor antagonist, macitentan, with prednisolone. As a result, her clinical condition improved dramatically.

Cite

CITATION STYLE

APA

Sugino, K., Kabuki, T., Shibuya, K., & Homma, S. (2018). Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension. BMJ Case Reports, 2018. https://doi.org/10.1136/bcr-2017-221755

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free